current treatment landscape of dlbcl
Published 3 years ago • 446 plays • Length 4:00Download video MP4
Download video MP3
Similar videos
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
0:46
advancements in the dlbcl treatment landscape
-
1:49
updates in the dlbcl treatment landscape
-
1:31
the current state of treatment for limited-stage dlbcl
-
29:38
dlbcl treatment approaches: what you need to know
-
10:07
understanding diffuse large b-cell lymphoma with bruce cheson, md, facp, faaas, fasco
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
3:12
an overview of the current treatment landscape of non-hodgkin lymphoma
-
4:13
benefit trial: isatuximab, lenalidomide, and dexamethasone /- bortezomib in newly diagnosed myeloma
-
2:39
the role of bispecific antibodies in the treatment landscape for r/r dlbcl
-
2:03
the current landscape of treatment for bpdcn
-
1:21
the current treatment landscape for scd
-
2:32
improving the treatment landscape for dlbcl patients
-
1:45
improving the frontline treatment of dlbcl
-
0:56
the current treatment landscape in cll
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
3:04
applying molecular understanding of dlbcl to management strategies
-
0:58
improving second-line treatments in dlbcl
-
1:51
vls-101: an adc for mcl and dlbcl
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl